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Abstract
We performed an extensive mutational analysis of the canonical mouse odorant receptor
(OR) M71 to determine the properties of ORs that inhibit plasma membrane trafficking in
heterologous expression systems. We employed the use of the M71::GFP fusion protein to
directly assess plasma membrane localization and functionality of M71 in heterologous
cells in vitro or in olfactory sensory neurons (OSNs) in vivo. OSN expression of M71::GFP
show only small differences in activity compared to untagged M71. However, M71::GFP
could not traffic to the plasma membrane even in the presence of proposed accessory pro-
teins RTP1S or mβ2AR. To ask if ORs contain an internal “kill sequence”, we mutated ~15
of the most highly conserved OR specific amino acids not found amongst the trafficking
non-OR GPCR superfamily; none of these mutants rescued trafficking. Addition of various
amino terminal signal sequences or different glycosylation motifs all failed to produce traf-
ficking. The addition of the amino and carboxy terminal domains of mβ2AR or the mutation
Y289A in the highly conserved GPCRmotif NPxxY does not rescue plasma membrane traf-
ficking. The failure of targeted mutagenesis on rescuing plasma membrane localization in
heterologous cells suggests that OR trafficking deficits may not be attributable to conserved
collinear motifs, but rather the overall amino acid composition of the OR family. Thus, we
performed an in silico analysis comparing the OR and other amine receptor superfamilies.
We find that ORs contain fewer charged residues and more hydrophobic residues distrib-
uted throughout the protein and a conserved overall amino acid composition. From our anal-
ysis, we surmise that it may be difficult to traffic ORs at high levels to the cell surface in vitro,
without making significant amino acid modifications. Finally, we observed specific increases
in methionine and histidine residues as well as a marked decrease in tryptophan residues,
suggesting that these changes provide ORs with special characteristics needed for them to
function in olfactory neurons.
PLOS ONE | DOI:10.1371/journal.pone.0141712 October 29, 2015 1 / 24
OPEN ACCESS
Citation: Bubnell J, Jamet S, Tomoiaga D, D’Hulst C,
Krampis K, Feinstein P (2015) In Vitro Mutational and
Bioinformatics Analysis of the M71 Odorant Receptor
and Its Superfamily. PLoS ONE 10(10): e0141712.
doi:10.1371/journal.pone.0141712
Editor: Johannes Reisert, Monell Chemical Senses
Center, UNITED STATES
Received: July 12, 2015
Accepted: October 12, 2015
Published: October 29, 2015
Copyright: © 2015 Bubnell et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by NIH SC1
GM088114 to SJ, JB, DT, CD and PF for
experiments. This publication was made possible by
a Research Centers in Minority Institutions Program
grant from the National Institute on Minority Health,
and Health Disparities (MD007599) of the National
Institutes of Health. Its contents are solely the
responsibility of the authors and do not necessarily
represent the official views of the NIMHD or the NIH.
Introduction
Since the first odorant receptor (OR) was cloned in 1991, major goals in the field of olfaction
have been to characterize and identify ligands for odorant receptors, to understand how olfac-
tory function affects human health, and to identify the mechanisms underlying olfactory per-
ception. These goals are still very far from being achieved. Although ORs make up the largest
family of seven transmembrane receptors (7TM) in the human genome, almost all of the
human odorant receptors are functionally uncharacterized [1].
Odorant receptors are located on the cilia of olfactory sensory neurons (OSNs) and bind
odorants from the environment, which leads to G-protein-mediated activation of the cyclic
AMP pathway. Excluding allelic variants, there are over 1000 intact OR coding sequences in
mice, and 350 in humans; each type of OR protein theoretically responds to a subset of odor-
ants delivered at low concentrations [2–4]. An effective high-throughput system of analysis is
required to understand the molecular basis of odor activation of this vast family of receptors.
Progress in the field of olfaction has been hindered by the lack of effective in vitro expression
systems for ORs. Compared to in vivo systems, in vitro systems provide a rapid and cost-effec-
tive means of analyzing the structure and the function of proteins.
Expressing ORs in heterologous cells has been met with minimal success due to endoplas-
mic reticulum (ER) retention of OR proteins. There has been some progress in trafficking
small amounts of receptor protein to the cell surface in vitro, but the receptor is often forced
out to the plasma membrane by signal leader sequence fusions, ignoring the properties that are
obstructing trafficking [5, 6]. These forcibly expressed ORs are not likely to be properly folded
and may not provide accurate ligand-binding profiles.
Moreover, for the past 20 years, many laboratories have used complementation assays to
identify proteins expressed in OSNs that would allow ORs to traffic out of the ER in heterolo-
gous cells. “Accessory proteins”, such as Receptor-Transporting Protein 1 and 2 (RTP1; RTP2)
and Receptor Expression Enhancing Protein (REEP), help to traffic some ORs to the plasma
membrane in vitro when they are co-expressed with an OR [7]. Both of these protein types are
natively and specifically expressed in olfactory neurons and interact with ORs. Although there
is evidence that ligand-binding profiles for ORs co-expressed with RTP and REEP are similar
to those in vivo, these accessory proteins do not enable plasma membrane expression for all
ORs [7]. Even more, the level of plasma membrane expression for each OR when co-expressed
with RTPs differs greatly and the successfully addressed ORs are usually tagged at the amino
terminus. This is a step forward in the search for factors involved in OR trafficking, but it is far
from a solution. However, insight into the mechanisms preventing ORs from plasma mem-
brane expression could be provided by closely examining the interactions between accessory
proteins and ORs.
Virtually all members of the OR superfamily tested either poorly traffic or show no traffick-
ing to the plasma membrane in vitro if they are expressed without cofactors. In contrast, other
G-Protein Coupled Receptors (GPCRs) like the canonical β2-Adrenergic Receptor (β2AR)
robustly traffic to the plasma membrane in heterologous cells [8]. We have begun to break
down the biological barriers that are preventing plasma membrane expression of ORs by
understanding how the β2AR traffics to the plasma membrane [9].
Here, we have developed an assay to analyze OR trafficking by generating OR Carboxy-ter-
minal (Ct) fluorescent protein fusions and expressing them in a cell line derived from the
mouse olfactory placode, OP6. Previous studies have shown that the fusion of the green fluo-
rescent protein (GFP) does not affect GPCR trafficking and ligand activation ([10]; [9]). We
have previously observed that the Ct fusion of GFP to the M71 OR (M71::GFP) neither affects
its trafficking to the cilia nor to the axons when expressed in vivo [11]. Here, we further validate
Mutational and Bioinformatics Analysis of Odorant Receptors
PLOS ONE | DOI:10.1371/journal.pone.0141712 October 29, 2015 2 / 24
Competing Interests: Dr. Paul Feinstein has
ongoing experiments in the field of olfaction with
Firmenich, Inc., and consults for Firmenich, Inc. as
well. He has no patents with Firmenich. None of the
experiments in this manuscript have any bearing on
his interactions with Firmenich, Inc. or vice versa.
This does not alter the authors' adherence to all the
PLOS ONE policies on sharing data and materials.
the functionality of M71::GFP by demonstrating its odorant sensitivity is nearly identical to
M71 when expressed in OSNs. In contrast, M71::GFP does not traffic to the plasma membrane
in heterologous cells.
We attempted to “fix M71” trafficking through extensive targeted mutagenesis and chimeric
analyses with the mouse β2AR (mβ2AR); we generated 29 mutants and co-expressed them
with RTP1S in vitro. The mutations target a range of OR sequences including conserved
regions between ORs not present in β2AR, N-linked glycosylation site modifications, and the
addition of signal leader sequences. Finally, we generated chimeras with β2AR and mutated a
conserved region (NPxxY; Y289A mutation) involved in mβ2AR trafficking [9]. None of the
mutations rescues plasma membrane trafficking.
These results indicate that the failure of ORs to traffic to the plasma membrane in vitro
might be a distributed effect of the amino acid composition. We performed a bioinformatic
analysis that reveals the OR superfamily has fewer charged residues and more hydrophobic res-
idues than non-OSN expressed amine or adrenergic receptors. Thus, there may not be a single
region of the OR protein, but rather a broad distribution of residues, which prevents functional
expression of ORs to the plasma membrane in heterologous cells.
Material and Methods
Plasmid construction
All constructs used in this study are listed in S1 Text. We used an in vitro expression vector for
the GPCR fusion constructs (D346) and the gap protein fusion constructs, as previously
described [10]. We codon optimized the M71 coding sequence for mouse to improve protein
expression in heterologous cells and used this sequence for all mutagenesis and chimeric analy-
ses. The mβ2AR coding sequence is from mouse strain 129 cDNA, as previously described
[12]. RTP1S was amplified from mouse olfactory cDNA with 5’ aaaagagctcaagcttc-
gaattcggcgcgccaccatgtgtaagagtgtga 3’ and 5’ ttaattaatcagacagaagtacggaaggagaat 3’ primers,
shuttled into the pGemT Easy vector (Promega).
We generated mutations and chimeric constructs using the following methods: for point
mutations we used primers designed for QuickChange mutagenesis (Stratagene), and all other
constructs and mutants were generated through PCR amplification and pGemT Easy ligation,
or through Gibson Assembly cloning directly into the D346 expression vector (New England
Biolabs Inc). Constructs in the pGemT vector were subcloned into the in vitro expression vec-
tor described above as EcoRI/PacI cassettes to generate GFP or mCherry GPCR fusions. See S1
Text for nucleotide and amino acid sequences and their plasmid names.
OP6 cell culture and transfection
Mouse olfactory placode cells were maintained (OP6 [13], a gift from Jane Roskams) as previ-
ously described [8] in Dulbecco’s modified Eagle’s medium (DMEM 1X Gibco) supplemented
with 10% fetal bovine serum (FBS Gibco) and 1% penicillin/streptomycin (Pen Strep Millipore)
at 33°C. We transiently transfected plasmid DNA constructs using the Amaxa Nucleofector
(Lonza) with PBS at 60%-70% confluency according to the manufacturer’s protocol. Trans-
fected cells were allowed to recover for 24 hours at 33°C and express the plasmid DNA before
imaging.
Laser scanning confocal microscopy
We live-imaged OP6 cells on a Zeiss LSM 510 microscope using a Zeiss Plan-APO 25X water
immersion objective in culture media. We excited GFP at 488 nm and collected at BP500-545
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nmmCherry at 561 nm and collected at LP575 nm. All images were acquired using the multi-
tracking feature.
Filopodia counts
We counted fluorescently labeled filopodia as a measure of plasma membrane trafficking as
described in [9]. To stain the plasma membrane, we used Cellmask Deep Red Plasma Mem-
brane reagent (Life Technologies) as described in [9].
Dose response to 2,4 dimethyl acetophenone
We performed the dose response assay by Calcium-based Fluorometric Imaging Plate Reader
(FLIPR) as previously described [8].
Electrophysiological recordings
Patch clamp recordings on OSN knobs was performed on epithelial explants as previously
described [14]. The Institutional Animal Care and Use Committee at Northwestern University
specifically approved these studies.
Bioinformatics
Logo plots were generated using the programs Clustal Omega (http://www.ebi.ac.uk/Tools/
msa/clustalo/) for multiple sequence alignment andWebLogo 3 (http://weblogo.threeplusone.
com/create.cgi). GPCR protein sequences were obtained from the GPCR database (http://
www.gpcr.org/7tm/). Our analysis of GPCRs was restricted to those with lengths between 270–
401 residues starting from the most amino terminal N-linked glycosylation motif, NxS/T/C to
the NPxxY at the end of transmembrane 7. See raw data (S1 Table) and accepted/discarded
sequences (S1 File).
Results
A GFP fusion to the C-terminus of M71 minimally affects its functionality
in vivo
There are few GPCRs that have been well characterized as N-terminal (Nt) or C-terminal (Ct)
GFP fusion proteins. We previously expressed in vitro, mβ2AR::GFP or various fluorescent
protein (XFP) Ct fusion proteins in heterologous cell lines. All versions of the mβ2AR::XFP Ct
had the same EC50 to a single high affinity agonist, isoprenaline as compared to the untagged
mβ2AR. No other pharmacological characterization of the mβ2AR::GFP fusion protein has
been performed either in vitro nor in vivo (no gene-targeted nor transgenic mice exist). In con-
trast, we have previously characterized the M71 OR protein (olfr151) fused to GFP in vivo.
M71::GFP is capable of localizing to olfactory cilia and axons as well as promoting axon out-
growth, axon identity, and glomerular formation in the mouse olfactory system [11]. However,
we did not compare its in vivo odorant response profile to the untagged M71 protein.
In 2003, only two M71 agonists had been identified, acetophenone and benzaldehyde. Acet-
ophenone proved to be a more reliable agonist with an EC50 of ~19.6μM. In 2012, we
described additional odorants that could specifically activate M71, but not its 96% homologous
paralogue M72 (olfr160). These odorants include ligands with higher maximal activations and
EC50s: 2-amino acetophenone (2aACP), 4-methyl acetophenone (4mACP), piperonal (PIP),
and ethyl maltol (eMLT) [14].
We reveal that olfactory neurons expressing either M71 or M71::GFP are activated by M71
specific ligands and not by M72 specific ligands methyl salicylate(mSal) and butyrophenone
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(BTP) (Fig 1A). In addition, the low affinity M71 ligand, benzaldehyde (EC50 ~98μM), acti-
vated neither M71 nor M71::GFP at 10μM. In contrast, the highest affinity M71 ligand,
2-amino acetophenone had nearly identical EC50s (0.65± 0.08 vs. 0.52± 0.1 μM) for M71 and
M71::GFP (Fig 1B). However, for 4-methyl acetophenone the M71::GFP EC50 was 10x lower
than M71 (1.5± 0.4 vs. 21.54± 6.43 μM). These results suggest that M71::GFP ligand binding
specificity has been mostly unaltered. However, there was a difference in 4-methyl acetophe-
none responsiveness, which might be explained by lower expression levels of the M71::GFP in
the plasma membrane compared to M71. Support for this proposal comes from our previously
reported M71 mutant that has an apparent 3-fold reduction in M71 levels in olfactory cilia,
also causes a 10-fold decrease in 4-methylacetophenone responsiveness without affecting the
2-amino acetophenone EC50 (Fig 1A and 1B). These data show that the M71::GFP fusion pro-
tein retains an EC50 and response profile for the highest-affinity M71 odors that appear refrac-
tory to receptor protein levels and the GFP Ct moiety.
GPCR::GFP plasma membrane trafficking using the GFP-filopodia
assay
To study heterologous expression of ORs we employed a cell line derived from the mouse olfac-
tory placode (OP). OP6 cells are OSN precursors and possess numerous filopodia most likely
due to their neuronal origins. We have previously shown that when a cytoplasmic fluorescent
protein is expressed in OP6 cells, few or no filopodia are fluorescently labeled. On the contrary,
when the fluorescent protein is fused to proteins that successfully traffic to the plasma mem-
brane, the protein locates to filopodia [10]. Thus, in order to quickly and accurately assess the
plasma membrane localization of GPCRs, we assay for the presence of GPCRs fused to the
green fluorescent protein (GPCR::GFP) within the filopodia of OP6 cells. Localization of this
fusion protein to the filopodia indicates successful trafficking to the plasma membrane and the
lack of labeling at the filopodia indicates non-satisfactory trafficking to the plasma membrane
[9].
We chose this OR as a preliminary example to dissect OR trafficking in vitro, because of the
wealth of in vivo ligands for M71. When we express M71::GFP in OP6 cells, no filopodia are
labeled with GFP and the receptor is localized perinuclearly (Fig 2A, 2C and 2E). On the con-
trary, when we express mβ2AR::GFP in OP6 cells, it localizes to the filopodia with an average
of 32 filopodia per cell across 10 cells, and thereby reflecting successful trafficking to the plasma
membrane (Fig 2B, 2D and 2E). To confirm the presence of filopodia in our transfected cells,
we stained the plasma membrane of OP6 cells with CellMask Deep Red Plasma membrane
stain, and observed the same number of filopodia for cells expressing either M71::GFP (33.8
±13.7 filopodia per cell) or mβ2AR::GFP (25.5 ±16.0 filopodia per cell). This result suggests
that the expression of different GPCR::GFP does not affect the number of filopodia in OP6
cells (Fig 2E). As expected, mβ2AR::GFP expression in the filopodia is almost always co-labeled
with CellMask but there is almost no detectable GFP fluorescence in the filopodia of M71::GFP
expressing cells: 25.4 ±16.1 double-labeled filopodia for mβ2AR::GFP vs. 0.6 ±1.6 for M71::
GFP (Fig 2B’ and 2D’).
Co-expression of M71::GFP with the short form of the OR accessory protein, RTP1
(RTP1S), reveals no labeled filopodia, confirming accounts from other labs that RTP1S does
not always rescue plasma membrane trafficking of the M71 OR [7]. Not surprisingly, when
mβ2AR::GFP is co-expressed with RTP1S, there was no difference in the number of labeled
filopodia, 27 vs. 32 per cell for 10 cells (Fig 2E).
Previous studies have suggested that co-expression of M71 and β2AR improves M71 traf-
ficking [15]. When we co-express M71::GFP and mβ2AR::mCherry, the M71 OR localizes
Mutational and Bioinformatics Analysis of Odorant Receptors
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Fig 1. Ex vivo profiling of M71::GFP fusion protein. (A) Peak currents for M71 (red), M71::GFP (green) and IRES-M71 (yellow) extracellular dendritic
knobs after excitation by seven odorants: five M71 specific odorants with variable affinities (mBNZ:benzaldehyde, 2aACP:2-amino acetophenone, eMLT:
ethyl maltol, PIP:piperinal, 4mACP:4methyl acetophenone) and two M72 specific odorants (mSal: methyl salicylate and BTP:butryophenone). Odorants
arranged by structure. Concentration for six odorants were all at 10μM except 2aACP was 1μM due to its higher affinity. The major difference observed was 2
fold higher peak current to 4mACP for M71 relative to both M71::GFP and IRES-M71. (B) Current traces for M71 and M71::GFP show similar desensitization
profiles to 2aACP and 4mACP regardless of 4mACP 1 log lower EC50. Single cell dose response curves for M71 (red), M71::GFP (green) and IRES-M71
(yellow) reveal a 1 log difference lower in EC50 to 4mACP relative to M71.
doi:10.1371/journal.pone.0141712.g001
Fig 2. M71::GFP does not traffic to the plasmamembrane. (A) M71::GFP expression in OP6 cells in trapped perinuclearly (A’) Same cell with colabelling
of plasmamembrane revealed by CellMask Red. (B) mβ2AR::GFP expression in OP6 cells gives a flat morphology that has sharp focus. Expression is
observed in filopodia. (B’) Same cell as (B) with colabelling of plasmamembrane revealed by CellMask Red. (C, D) M71::GFP and mβ2AR::GFP expression
vectors. (E) Filopodia counts by Cell Mask Red and GFP for mβ2AR::GFP and mβ2AR::GFP. (F) M71::GFP co-expression with mβ2AR::mCherry in OP6
cells maintains GFP fluorescence trapped perinuclearly whereas (F’) mβ2AR::mCherry expression is found in the filopodia.
doi:10.1371/journal.pone.0141712.g002
Mutational and Bioinformatics Analysis of Odorant Receptors
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perinuclearly, whereas the mβ2AR successfully traffics to the plasma membrane and labels filo-
podia (Fig 2F and 2F’). Thus, in the same cell in which mβ2AR::mCherry successfully traffics
to the plasma membrane and M71::GFP does not, providing a good internal control that indi-
vidual OP6 cells retain the capacity to properly traffic GPCRs. These results indicate that reten-
tion of M71 in the ER does not prevent β2AR trafficking to the plasma membrane and mβ2AR
is not a cofactor for the trafficking of M71.
Conserved OR superfamily specific residues do not prevent M71 plasma
membrane trafficking
To better understand what prevents OR expression in heterologous cells, we performed a mul-
tiple sequence alignment (MSA) using Clustal Omega of OR predicted proteins to look at con-
served residues that might play a role in the retention of ORs in the ER. An OR logo plot for
the MSA depicts sparse conservation (Fig 3A; Near 100% conservation is distributed to a hand-
ful of residues in OR Logo plot; 47/302 residues; see also [16]). The overall protein homology
between the M71 OR and the mβ2AR is very poor, even though the mβ2AR can act as a surro-
gate OR in vivo (18%: 56/302 residues; 5% is considered random, which would be 15/302 resi-
dues). The M71 and the mβ2AR conservation within the transmembrane domains is sparse,
16/56 residues (Fig 3A; TM1, GN residues; TM3, DRYVAI residues; and in TM3, NPLIY resi-
dues)[11]. These residues also are conserved within the OR superfamily.
We wanted to determine if there were sequences specific to ORs that caused their ER reten-
tion. Logo plots between GPCRs, ORs and vomeronasal receptors (V1Rs) were compared to
identify residues that are conserved across non-chemosensory GPCRs but have different con-
servations in either ORs or V1Rs. We mutated sequences conserved only amongst ORs or
V1Rs and not found in mβ2AR. In addition, we mutated selected regions of M71 that differed
from mβ2AR; Residues in M71 sequences were either replaced with those of the mβ2AR or
alanine.
M71::GFP mutants were subsequently tested in our GFP-labeled filopodia assay for plasma
membrane expression in OP6 cells. The first group of mutations were as follows: FILGG (resi-
dues 12–16) to DHDVT, Y35A, PMY(residues 58–60) to VTN, M98E, C169A, YF (residues
176–177) to TC, C178A, and Y217A. These mutations targeted the OR superfamily conserved
residues: FxLxG12-16, PMY58-60, Y35, Y217A and residues involved in the formation of disul-
fide bridges between conserved cysteines: M98, C169, and YF176-177.
None of these OR specific sequences appear individually responsible for the ER retention of
heterologously expressed M71::GFP mutants as they did not traffic to the filopodia (Fig 4A).
To determine if a combination of the homologous sequences were preventing plasma mem-
brane trafficking, we generated a single construct with all of the sequence mutations. There
were no observable GFP-labeled filopodia, therefore failure to traffic to the plasma membrane
is not due to a combination of these sequences (Fig 4A). Furthermore, co-expression of RTP1S
with any mutant did not rescue plasma membrane trafficking (Fig 4A). We were surprised that
there was no variation in the non-trafficking phenotype. This led us to believe that other resi-
dues might have a stronger influence on trafficking.
It should be noted that the lack of M71::GFP fluorescence in filopodia of OP6 cells is not an
intrinsic feature of the assay system. One OR gene that has been very well characterized in a
modified HEK293 cell line, is the human OR, OR1A1 [17]. We reasoned that ligands have been
identified for this receptor due to some aspect of OR1A1’s amino acid code escapes the classical
inability of ORs to traffic in heterologous cell lines (S1A Fig). To confirm our suspicions, we
created OR1A1::GFP and expressed it in OP6 cells. GFP-labeled filopodia were identified in
many cells (20/20) with an average of 13.7±10.8 (S1B and S1C Fig), which is certainly less
Mutational and Bioinformatics Analysis of Odorant Receptors
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robust than mβ2AR. Thus, our assay can detect filopodia for the trafficking of an OR. The
amino acid homology of OR1A1 to mβ2AR is only 14% (43/302 residues), which is similar to
the 56/302 observed for M71 and mβ2AR (S1A Fig). In addition, the most highly conserved
OR superfamily residues in common with mβ2AR are 17/47 for OR1A1, which is similar to the
18/47 for M71, whereas 45/47 residues are conserved with OR1A1 and 46/47 for M71. Thus,
OR1A1 and M71 share the same degree of homology with each other compared to the OR
superfamily and to mβ2AR, yet OR1A1::GFP does traffic to the plasma membrane and M71::
GFP does not. These observations further imply that the highly conserved residues are most
likely not involved in retention of M71.
Fig 3. Conserved OR sequences revealed by logo plot shared with M71 andmβ2AR. (A) OR logo using mouse Class I and II odorant receptor
sequences. Most highly conserved OR residues are depicted with black circles. M71 and mβ2AR sequences are delineated underneath logo plot; Residues
with greater than 50% bit conservation to OR logo are underlined. Conserved residues between M71 and mβ2AR are in bold and red. M71 residue swaps
between M71 and mβ2AR are delineated in purple and green, respectively. M71 residues converted to alanine are described with bold blue A. Five
conserved methionine residues, three conserved histidine residues and one weakly conserved tryptophan residue marked with asterisk. Two of these
residues are also found in OSN expressed TAARs marked with red asterisk. (B) Schematic of OR seven transmembrane structure with conserved
methionine and histidine residues depicted in linear and predicted 3 dimensional state. Methionine and histidine residues in non-transmembrane might be in
close enough proximity to coordinate a metal group, like copper. Methionine residues in TM3 and TM7may form bridge if modified.
doi:10.1371/journal.pone.0141712.g003
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Fig 4. M71::GFP directedmutations that do not traffic to plasmamembrane. (A) M71::GFP mutations F12D;I13H;L14D;G15V;G16T (FILGG to
DHDGG), Y35A, P58V;M59T;Y60N (PMY to VTN), M98E, C169A, Y176T;F177C (FY to TC), C178A and Y217A. None of these mutations gave raise to any
GFP-labeled filopodia. (B) M71::GFPmutations with N-linked glycosylation modifications: 4x NQS, 4x NSS, NQS to NGT, NQS to NAT, Nt to K4 Nt. (C)
Addition of leader sequences (Kirrel2, 5HT3, Calcumenin, Rhodopsin, Endothelin, LUCY and LUCY-FLAG) to M71::GFP did not relocate GFP expression
into the filopodia. (A-C) Co-expression with RTP1S for all M71::GFPmutations did not increase the presence of any GFP-labeled filopodia.
doi:10.1371/journal.pone.0141712.g004
Mutational and Bioinformatics Analysis of Odorant Receptors
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OR specific N-linked glycosylation properties do not prevent M71
plasma membrane trafficking
N-linked glycosylation at the amino terminus of GPCRs is considered to be a crucial post-
translational regulatory step for targeting plasma membrane expression of the protein [18].
The consensus amino acid sequence NxS/T in the amino terminus marks the protein for glyco-
sylation. In ORs, there is usually only one N-linked glycosylation site in the N-terminus (Nt),
whereas many other GPCRs contain multiple sites. To test for the role of these sequences on
the membrane trafficking of M71::GFP, we generated 5 Nt mutations in M71 (Fig 4B).
M71 has only one N-linked glycosylation site, NQS. We increased the number of NxS/T
sequences and assayed for plasma membrane trafficking by adding 4 copies of the OR sequence
NQS or 4 copies of the N-linked glycosylation sequence, NSS (as in the mβ2AR) (perhaps bet-
ter able to be recognized). Neither of these mutations could rescue any observable plasma
membrane trafficking.
The addition of 20 amino acids from the Nt of the human Rhodopsin to the Nt of some ORs
has been previously reported to improve OR release from the ER. This 20 amino-acid sequence
contains two potential glycosylation sites which may contribute to OR plasma membrane traf-
ficking. Replacement of the NQS sequence in M71 with each one of the two N-linked glycosyla-
tion sites found in the Nt of the human Rhodopsin, NGT and NAT did not instruct plasma
membrane expression. We then added the full Rhodopsin “tag” to the Nt of M71, but it also
failed to allow for M71::GFP trafficking to the filopodia (Fig 4C.; see below: addition of signal
leader sequence).
Finally, The Nt of the OR K4 contains a non-consensus N-linked glycosylation sequence
(NHCT; [19]). Replacement of the first 7 residues of the M71 Nt with those of the K4 OR had
no effect on plasma membrane trafficking. We observed the same results when all mutant con-
structs were co-expressed with RTP1S. These results indicate that the addition of multiple and
various N-linked glycosylation sites at the Nt of ORs is not sufficient to restore trafficking to
the plasma membrane.
Addition of signal leader sequences does not rescue M71 membrane
trafficking
Since the addition of signal leader tags to GPCRs has provided some success in trafficking vary-
ing amounts of receptor protein to the plasma membrane, we analyzed the effect of various sig-
nal leader tags on plasma membrane expression of M71. We tested the rescue potential of
seven N-terminal signal leader fusion tags: Kirrel2, Calcumenin, 5HT3, Rhodopsin, Endothelin
Receptor B, Leucine Rich Repeat Containing 32 (LLRC32)-LUCY, and LUCY plus FLAG.
None of the seven tags improved cell surface expression in our assay alone or in the presence of
RTP1S (Fig 4C). Several studies showed that RTP1S has a synergistic effect with the addition of
Nt tag sequences on ORs. However, in our assay we did not observe such phenomena.
The Nt and Ct of M71 alone do not prevent plasma membrane
expression
We have recently characterized a series of mβ2AR::GFP mutants for their ability to plasma
membrane traffic in OP6 cells [9]. Through chimeric analyses with M71, we observed that
mβ2AR chimeras with both the Nt and Ct of M71 disrupted plasma membrane trafficking.
This synergistic effect appeared intramolecular in origin. Thus, an interaction between the Nt
and Ct may be preventing the proper release or folding of ORs in the ER. To test this hypothe-
sis, we replaced the Nt region of M71 with that of mβ2AR so that the region would have
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structural similarity to that of a trafficking GPCR (Fig 5). We also replaced the C-terminal (Ct)
region of M71 with the much longer Ct of mβ2AR. Neither chimera proteins trafficked to the
plasma membrane in the presence or in the absence of RTP1S. In addition, swapping both the
Nt and Ct of M71 with those of the mβ2AR did not allow for plasma membrane localization
(Fig 5A). Therefore, the Nt and the Ct of M71 are not preventing plasma membrane trafficking
of its core seven transmembrane domains.
A Tyrosine 289 mutation (Y289A) within the NPxxY motif of M71 does
not rescue membrane trafficking
We have recently reported that the deletion of the Ct (ΔCt) of the mβ2AR blocks its trafficking
to the plasma membrane [9]. Surprisingly, the Y326A mutation in a conserved motif at the end
of TM7 (NPxxY; [9]) was able to rescue plasma membrane trafficking in the ΔCt mβ2AR.
These data may indicate that M71 does not traffic due to Nt and Ct interactions and/or that the
M71 Ct behaves like the mβ2AR ΔCt. Thus, we generated the Y289A mutation in the conserved
NPxxY motif of M71 in the context of different Nt or Ct or with a ΔCt (Fig 5B). We observed
no plasma membrane trafficking of M71 with the Y289A mutation in the context of full-length
M71, ΔCt, mβ2AR-Nt, mβ2AR-Nt and ΔCt, or mβ2AR-Nt, -Ct. In addition, the co-expression
of RTP1S had no effect on plasma membrane trafficking of those mutants (Fig 5B).
Finally, we tested if ligand activation is possible in absence of plasma membrane expression
of our M71::GFP mutants. We expressed several of the previously described M71::GFP mutants
Fig 5. M71::GFP chimeras and truncations that do not traffic to plasmamembrane. (A) M71::GFP chimeras with Nt-mβ2AR, Ct-mβ2AR, Nt-and Ct-
mβ2AR. None of these chimeras led to GFP-labeled filopodia. (B) Altered NPxxYmotif, Y289AM71::GFPmutants, with altered Nt and Ct: WT, ΔCt, Nt-
mβ2AR, Nt-mβ2AR/ΔCt, and Nt- and Ct-mβ2AR. None of these chimeras led to GFP labeled filopodia. (A and B) Co-expression with RTP1S for all M71::GFP
mutations did not increase the presence of any GFP-labeled filopodia.
doi:10.1371/journal.pone.0141712.g005
Mutational and Bioinformatics Analysis of Odorant Receptors
PLOS ONE | DOI:10.1371/journal.pone.0141712 October 29, 2015 12 / 24
in heterologous cells and exposed the cells to 1mM or less with the odor 2-4-dimethyl-aceto-
phenone, which gives the maximum response in M71 expressing OSNs. We did not observe
any response in our dose-response assay, performed in HEK 293, for M71::GFP, M71::GFP
with Kirrel 2 tag, M71::GFP with LUCY-FLAG tag, M71::GFP with mβ2AR-Nt, -Ct or M71::
GFP with mβ2AR-Nt, -Ct and Y289A. We were not surprised by the lack of M71 functionality
in heterologous cells, but we were surprised that there was no noticeable improvement of
plasma membrane trafficking by site directed mutagenesis, tags or as a chimera with mβ2AR.
The amino acid composition of odorant receptors is unique amongst
GPCRs
Distant members of the OR superfamily can share as little as 18% homology and so a natural
conclusion may be that conserved residues amongst ORs are responsible for the observed lim-
ited plasma membrane expression in heterologous cells. However, twenty-nine M71 OR
mutants did not traffic to the plasma membrane in our in vitro structure-function assay. In
addition, transfection with OR51E2::GFP, mOR-EG::GFP (olfr73), and mTAAR4::GFP did not
show GFP-labeled filopodia, although a few were observed with mOR-EG::GFP when co-trans-
fected with RTP1s (data not shown). These observations indicate that conserved residues may
not be responsible for limiting OR expression in vitro, so perhaps the non-conserved residues
are contributing to the phenomena. To explore this possibility we have taken a comparative
bioinformatics approach to determine if any non-conserved residues have a common character
in ORs but not amongst other GPCRs and if particular residues are distributed in a pattern in
functional domains unique to ORs.
We extracted sequences from the GPCR database for all amine receptors (Amine) and all
odorant receptors (ORs) from many species. In addition, we created two subgroups of all
amine receptors: all adrenergic receptors (Adrenergic) and all trace amine-associated receptors
(TAARs). Both ORs and TAARs are used in the olfactory system to recognize odors. Notably,
not all members of the amine receptor superfamily can be functionally expressed in vitro in
heterologous cells. Within this superfamily, adrenergic receptors are easily expressed in vitro
whereas TAARs require the rhodopsin 20 amino acid Nt tag and co-expression with OR cofac-
tors (RTP1S/RTP2, REEP1 and Ric8b) [20].
We further refined these sequences to likely functional proteins by excluding pseudogenes
with intact coding sequences. The sequences we included must contain two highly conserved
motifs: an amino terminal NxS/T glycosylation site and NPxxY motif (resides at the end of
transmembrane 7) at distances of 270 to 401 residues. Our final sequences from multiple spe-
cies for analysis consist of 289 adrenergic receptors, 525 TAARs, 1803 amine receptors, and
12007 odorant receptors (S1 Table).
We then created an amino acid residue profile of all 20 amino acids across these sequences
and ranked them by hydropathy index (Fig 6A; [21]). The hydropathy index of an amino acid
is a number representing the hydrophobic or hydrophilic properties of its side chains. The
larger the number is the more hydrophobic the amino acid. Hydrophobic residues are most
commonly found to be internal to a protein, while hydrophilic amino acids tend to be at the
surface of the protein. GPCRs contain seven transmembrane domains that directly contribute
to their functionality. Not surprisingly, we observed that residues with nonpolar/neutral side
chains were highly represented, whereas the residues with polar/charged side chains were
poorly represented (Fig 6A). This trend was comparable between the amine and ORs. It should
be noted that adding back the rejected sequences did not change our conclusions.
Next, we compared the representation of each residue across ORs and TAARs. We first nor-
malized the percent difference of each residue in the ORs and TAARs to those of the adrenergic
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receptors, as they successfully traffic to the plasma membrane in vitro. We compared the percent
difference of each residue between ORs and Amines as well as TAARs vs. Amines. Surprisingly,
we saw that both the ORs and TAARs had similar residue composition relative to the Amines with
a few notable exceptions: Methionine (M) and Histidine (H) were ~3x more likely to occur in ORs
than TAARs and Tryptophan (W) was ~3x less likely to occur in ORs than TAARs (Fig 6B).
ORs and TAARs have increased hydropathy profiles
GPCRs belong to the 7TM receptor superfamily where each transmembrane segment requires
approximately 20 amino acids with an alpha helix and hydrophobic character to pass through
Fig 6. Amino acid residue composition of Adrenergic, Amine, Odorant and Trace amine-associated receptors. (A) Amino acid percentages for
Adrenergic, Amine, Odorant (ORs) and Trace amine-associated Receptors (TAARs). ORs and TAARs profiles differ from Adrenergic and Amine receptors.
(B) Amino acid differences for ORs and TAARs expressed as percentage difference from Amine receptors. Many residues show an increase in proportion
(positive percentage) and decrease in proportion (negative percentage). Three residues for ORs show a large, 60% difference (methionine-M, histidine-H
and tryptophan-W). These three residues also show large differences from TAARs with methionine and histidine comprising the bulk of the statistical
difference between them. Results did not change if TAARs and Adrenergic receptors were removed from the Amine receptor superfamily. Amino acids are
ordered according to their hydropathy index from 4.5 to -4.5 (L to R). It appears that most of the residue differences favor ORs and TAARs to be more
hydrophobic.
doi:10.1371/journal.pone.0141712.g006
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the lipid bilayer. Thus, a typical OR or TAAR coding sequence contains approximately 140 res-
idues with a hydrophobic character out of ~320 total residues (~44%). Our analysis of the
amino acid usage profile for ORs and TAARs suggested they might have greater hydrophobic
character than typical GPCRs. Indeed, we observe that ORs and TAARs relative to amine
receptors contain more residues with nonpolar/neutral side chains and fewer residues with
polar/charged side chains (Fig 6B).
The Hydropathy index (HI) assigns values from -4.5 to 4.5 for each amino acid [21] where a
value of 4.5 indicates that amino acid is most likely to be found in a transmembrane domain.
When we compare the residues with negative hydropathy indexes (single residue codes: G, T,
S, W, Y, P, H, D, E, N, Q) versus positive hydropathy indexes (single residue codes: I, V, L, F,
C, M, A), an overall 4% decrease in negative HI values and an overall 4% increase in positive
HI values for ORs relative to both Adrenergic and Amine receptors were observed (Fig 7,
inset). By contrast only a 2% change in the high and low HI values for TAARs is found com-
pared to the amine receptor superfamily. These changes translate into a net increase in twelve
hydrophobic residues for an OR and six for a TAAR coding region. However, the percentage of
total positive and negative HI-residues for Adrenergic receptors were nearly identical to the
Amine receptor superfamily. To determine how the increase or decrease in HI observed for
each residue translated into increased hydropathy of ORs we multiplied the percent difference
of each amino acid with its associated HI value. A positive value indicates that this residue
change would promote the hydropathy of a protein (positive percent residue difference x posi-
tive HI value and negative percent residue difference x negative HI value) (Fig 7).
We find that all residues enriched in ORs and TAARs except for histidine either have no
effect or promote hydropathy for both the ORs and TAARs (Fig 7). The gain of isoleucine (I),
leucine (L), phenylalanine (F), and methionine (M) residues and loss of tryptophan (W), glu-
tamic acid (E), asparagine (N), lysine (K), arginine (R) residues promoted hydropathy for both
ORs and TAARs, but nearly all were substantially higher in ORs (Fig 7). In TAARs, only glu-
tamic acid (E) and arginine (R) are similarly fewer in percentage compared to ORs. However,
we observe a 60% increase in histidine (H) residues for ORs, which translated into the largest
net negative hydropathy, values for ORs and was 75% greater than TAARs (Fig 7). Thus, all
residues enriched in ORs and TAARs impart greater hydropathy values with the exception of
histidine (H) in ORs, and suggest that histidine (H) likely provides ORs with a specific function
that cannot be substituted by another amino acids.
Distribution profiling of Histidine, Methionine and Tryptophan residues. Our analyses
of amino acid usage have revealed greater representation of histidine (H) and methionine (M)
residues and lower representation of tryptophan (W) residues in ORs and TAARs compared to
Amine receptors. The functional implications of this difference may differ if the distribution of
H, M, and W residues were broadly distributed throughout the protein versus localized to par-
ticular protein domains (Fig 8; S2, S3, S4 and S5 Figs).
We analyzed the distribution of H and M residues for Adrenergic, Amine, ORs and TAARs
and reveal broad distribution patterns. Interestingly, within these broad distribution patterns,
we see specific localization of some of these residues at particular sites in ORs. There are three
notable exceptions for H residues and five for M residues with all eight being highly conserved
(Fig 3). Interestingly, 7/8 peaks correspond to conserved sequence motifs found in predicted
intracellular (IC), extracellular (EC) or transmembrane (TM) portions of the ORs: LHTPMY
(IC1), PKML (EC1),MAYDRYVAIC (end of TM3),HFFCD (EC2), CSSH (IC3), PMLNPLIY
(end of TM7). The role of the EC motif PKML is unknown, butHFFCD may bind metal ions.
The IC located motifs:MAYDRYVAIC, CSSH and PMLNPLIY are likely involved in signaling
events. The intracellular portion LHTPMY has no known function, but when PMY is mutated
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to VTN in M71::GFP (Fig 4), we observe no change in plasma membrane trafficking in heterol-
ogous cells.
Finally and very surprisingly, we observe that W residues are nearly absent in ORs. For
Adrenergic receptors, Amine receptors and TAARs, W residues are found at the Ct, and for
Adrenergic receptors and TAARs, W residues are also found within two internal clusters. The
rare W residue in ORs is within TM4, which is a highly conserved position within TM4 across
several superfamilies: ORs, TAARs, Vomeronasal receptors (VRs), Adrenergic families (Figs 3
and 8; S2, S3, S4 and S5 Figs). We also observe dispersed peaks of W residues in Adrenergic
receptors and TAARs within the middle portion of the protein. This observation reveals a lack
of sequence length conservation between these receptor groups whereas sequence length
Fig 7. ORs and TAARs have greater hydrophobic character than Adrenergic and Amine receptors. The percent difference in ORs and TAARs
compared to Amine receptors was multiplied by the hydropathy index (HI) of each residue. Positive percent differences x positive HI values and negative
percent differences x negative HI values increase the hydrophobic character to ORs. Many residues had increased the hydrophobic character or no effect.
Histidine showed the most significant difference overall and in relation to TAARs. Amino acids are ordered according to their hydropathy index from 4.5 to
-4.5 (L to R). (Inset) The positive and negative hydrophobic character of Adrenergic, Amine, ORs and TAARs wre calculated by adding together all residues
that contribute to non-polar/neutral or polar/positive-negative hydropathy index and calculating the percentage relative to the total residues. There was a
greater percentage of positive hydropathy and reduced negative hydropathy values for ORs and TAARs compared to Adrenergic and Amine receptors. This
translated into higher ratios of polar/neutral to polar/positive-negative residues.
doi:10.1371/journal.pone.0141712.g007
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Fig 8. Distribution of Methionine, Histidine and Tryptophan in Adrenergic, Amine, OR, TAAR receptors. (A) Distribution of histidine residues; (B)
Distribution of methionine residues; and (C) Distribution of tryptophan residues in Adrenergic, Amine, Odorant, and Trace amine-associted receptors. The
frequency of occurrence is displayed from NxS/T to NPxxY conservedmotifs, however the graphs are all anchored by the Ct NPxxY motif. Three histidine
and five methionine residues are found at discrete regions in ORs compared all other receptor types (blue and black asterisks); See Fig 3 for exact position.
Tryptophan residues are nearly abolished in ORs with only one conserved position (red asterisk), but distributions are conserved between TAARs and
Adrenergic receptors.
doi:10.1371/journal.pone.0141712.g008
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conservation is maintained in ORs (95% of ORs have the same length of ~286 residues from
NxS/T/C to NPxxY). In conclusion, only a single W residue appears weakly conserved amongst
ORs compared to conservation of M and H residues, and no W residues are observed in the
predicted M71 protein (Figs 3 and 8C).
Discussion
To efficiently characterize and identify ligands, GPCRs have been expressed in heterologous
cell lines. Many of the earliest identified GPCRs including Rhodopsin and β2 adrenergic recep-
tor (β2AR) robustly express in culture, which has made their detailed characterization possible.
Since the identification of ORs twenty-five years ago there has been persistent effort to
express them in heterologous cell lines and identify odors or ligands they are capable of binding
[22]. OR expression in cells is typically poor with most protein localized to the ER or intracellu-
lar compartments and absent at the plasma membrane [23]. Several laboratories have identified
protein cofactors (RTP1S, RTP2, REEP1, Ric8b) that rescue some OR protein expression at the
plasma membrane when co-expressed with ORs, albeit at extremely low levels compared to the
overall protein expression. However, these assays require the OR to be tagged at the amino ter-
minus tags for plasma membrane expression. These tags range from HA, FLAG, Rho or the
recently identified LUCY or LUCY-FLAG. Co-expression of tagged ORs along with several
cofactors can confer some plasma membrane in several heterologous cell lines including
HEK293T and its derivative HANA3A.
These tools for limited plasma membrane expression do not work with all ORs. The M71
OR is one such receptor that is refractory to in vitro expression and targeting to the plasma
membrane. However, the in vivo functionality of the M71 OR in OSNs has been described in
depth with regards to genetic and physiological mechanisms and its protein localization utiliz-
ing immunohistochemistry.
In vivo characterization of Ct-tagged ORM71 with GFP
To better model and describe M71 protein distribution and function in live olfactory neurons
we tagged the Ct of the protein with GFP. We have successfully used this method for analyzing
the expression of an other GPCR, the β2AR [10]. We previously generated gene-targeting mice
expressing the M71::GFP fusion to define M71 protein localization. We detected GFP in both
olfactory cilia and surprisingly olfactory axons during the process of glomerular formation in
the olfactory bulb [11]. M71 specific antibodies substantiated both results [24]. In the olfactory
system, interactions between like axons lead to their coalescence into specific glomeruli. It is
the OR sequence that imparts this axonal identity to these axons. The homogeneous glomeruli
formed fromM71::GFP expressing axons located close to the M71 glomeruli, as posterior but
more dorsal. Oddly, M71::GFP glomeruli and M71 glomeruli were distinct; axons of each
group did not coalesce with the other OR identity. One possibility for this differential axonal
identity and glomerular formation could be fromM71::GFP having reduced or modified
expression or function. We have already generated a second M71 mutation, which was engi-
neered to express less M71 (IRES-M71), which formed glomeruli 1.5mm anterior and ventral
to the normal M71 and M71::GFP glomeruli. OSNs expressing IRES-M71 retain identical func-
tionality of M71 to the high affinity agonist 2aACP despite a 3x reduction in protein in the
olfactory cilia. But, the lower affinity agonist 4mACP was altered by one log EC50 in
IRES-M71 neurons [14].
Here, we have functionally characterized the M71::GFP expressing OSNs with 7 odors: five
that have robust affinity for M71 and two that have high affinity for the OR M72, which shares
96% amino acid identity with M71. All five odors that activate M71 also activate M71::GFP
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whereas both odors that activate M72 fail to activate M71::GFP. However, we find that odorant
4mACP has one log higher EC50 to M71::GFP comparable to the IRES-M71 profile. Thus, on
first approximation M71::GFP is phenotypically expressed at the same level as IRES-M71,
which is 3x lower than M71. It is likely that either M71::GFP and IRES-M71 protein is
expressed at the same level or M71::GFP has 3x less functional protein at the membrane. It
seems unlikely that G-protein coupling was globally affected, as the dose response profiles of
the higher affinity agonists were the same.
The characterization of IRES-M71 neurons with all 7 agonists reveals a slightly broadened
response and includes the M72 specific ligand BTP (Fig 1), which was not observed for M71::
GFP neurons. So why does IRES-M71 have a different response to BTP or perhaps more
importantly, does IRES-M71 differ functionally fromM71::GFP or M71? When M71 is
expressed from an IRES sequence, translation is initiated at the start codon within the IRES,
but there is an upstream in-frame start codon that may add four additional amino acids
(MATT). We have recently shown that Nt and Ct interactions affect OR trafficking and Ct
mutations affect functionality, thus it is possible that the addition of the 4 amino acids, MATT,
might alter G-protein coupling efficiencies and lead to the slight BTP excitation [9].
There are four clear conclusions from the in vivo analysis of M71::GFP. First, addition of
GFP to the Ct has minimal affects on the signaling capacity of M71 or the position of glomeru-
lar formation as the M71::GFP glomeruli is in close proximity to the M71 glomeruli. Second,
we did not observe a lower maximum response for M71::GFP using any of the odors, but we
did observe one log changes in EC50 for 4mACP. This is in contrast to our previous study
regarding the mβ2AR::GFP revealed a lower maximum response rate [10], which suggests a
change in level of functional protein expression. Third, the mβ2AR::GFP may have differential
response profiles from mβ2AR should a broader ligand range be tested. Finally, if the potential
for odor-evoked activity of the OR were a significant feature of positional shifts in glomerular
formation, then the position of glomerular formation for M71::GFP and IRES-M71 should
have been the same. In this regard, M71 and M72 project to similar locations in the bulb
despite the M72 odor-evoked profile being significantly different fromM71 and IRES-M71,
which both have very similar odor-evoked profiles. Thus, the most likely cause of IRES-M71
glomerular formation at such a different location from M71, M71::GFP or M72 is due to a
change in its axonal identity code (alteration of its 309 residues) such as the addition of four
residues in the Nt or an unanticipated truncation. To translate these differences into a 1.5mm
shift in glomerular formation suggests that OR multimers might be involved to amplify what
appears to be a minor modification of the protein.
M71::GFP does not traffic to the plasma membrane in heterologous cells
We have successfully described the localization of mutant mβ2AR protein using Ct GFP
fusions in OP6 cells and have implemented this tool to characterize M71 signaling properties
in vitro and in vivo (OSNs). The Ct GFP modification does not appear to interfere with recep-
tor trafficking in vivo and only slightly alters the signaling efficacy ex vivo of our tested M71
specific odors.
To determine if there are amino acids within the ORs that prevent functional plasma mem-
brane expression in vitro, we made a series of M71 mutants visualized with the Ct GFP tag.
These mutations targeted conserved residues amongst ORs, conserved residues not known to
be involved in signal transduction, N-linked glycosylation additions, Nt tags, and chimeric
receptors with mβ2AR (Figs 4 and 5). None of these mutations or a combination of these
mutations altered plasma membrane trafficking even when co-expressed with RTP1S.
Although we were unable to identify a modifiable sequence to restore plasma membrane
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trafficking, we did set up an assay for potential rapid screening of OR mutants derived by ran-
dom mutagenesis.
Initially we made subtle mutations to M71 that might not affect G-protein coupling, but
when those failed to affect trafficking, we generated mutations that were more likely to affect
the overall structure of the protein and coupling efficiencies. When larger domain swaps of
M71 did not affect trafficking, we concluded that there might be a broad feature of ORs that
was preventing functional expression in heterologous cells.
Why does robust functional expression of ORs appears limited to OSNs in the olfactory sys-
tem where they act to identify odors in the nasal mucosa? Two simple possibilities emerge:
First, OSNs express specific cofactors such as RTP1S that might help shepherd ORs to the
plasma membrane, but RTP1S does not help all ORs including M71 traffic to the plasma mem-
brane in heterologous cells. This indicates that the presence of an olfactory specific cofactor is
not necessarily sufficient to rescue the trafficking deficit. Perhaps multiple cofactors are
needed. Second, the lipid composition of OSNs could be unique and it is this environment that
permits OR insertion into the plasma membrane. It is possible that ORs cannot traffic in heter-
ologous cells as a result of a combination of necessary cofactors, lipid modifications, and the
hydrophobic character, which we report, that all contribute to successful OR plasma mem-
brane trafficking in OSNs. The need for OSN specific cofactors or lipids could be tested in
OSNs cultured in vitro and forced to overexpress an OR.
OSN expressed ORs and TAARs are enriched in hydrophobic character
There is very limited homology amongst distant members of the OR superfamily as revealed by
their amino acid sequence alignment. But, homology is found amongst highly conserved resi-
dues, many of which are conserved in GPCRs outside of ORs. Thus, if any single conserved res-
idue across ORs were contributing to the suppression of plasma membrane trafficking, our
extensive mutagenesis might have identified it. By inference, if the OR conserved residues are
not contributing to the inhibition of OR trafficking in heterologous cells, then it is the non-con-
served residues that are likely playing a role in plasma membrane trafficking.
We took a comparative bioinformatics approach to determine if the protein properties of
ORs and TAARs differed from Adrenergic and Amine receptors. The Nt and Ct of ORs and
TAARs are usually short, whereas the Nt and Ct of Amine and Adrenergic receptors are usually
longer. We confronted this difference in our mutagenesis analysis and determined that the
length of the Nt and Ct were not contributing to plasma membrane trafficking. We then asked
if the core sequences between the amino terminal N-linked glycosylation sites and TM7 motif,
NPxxY differed in hydrophobic character among the superfamilies.
Our in silico analysis revealed that 19/20 amino acid residues either had no affect on or
increased the hydrophobic character of ORs and TAARs. Interestingly, despite a negative HI,
histidine has the single greatest contribution of a residue to the overall hydrophobic character
of an OR. But, the negative HI of histidine was dwarfed by the total hydropathy contribution of
the other 19 residues. Methionine residues are also more prevalent in ORs compared to Adren-
ergic and Amine receptors and we speculate that it may act to provide a balance to the hydro-
philic addition of histidine in the tertiary structure. Both residues appear in highly conserved
motifs, but only appear together in one of them, LHTPMY (Fig 3). None of the histidine resi-
dues (0/3) and only two methionine residues (2/5) are found in transmembrane regions (Fig
3). It is possible that these residues may contribute directly to the tertiary structure of the OR
in order to compensate for its overall enriched hydrophobic character. Mutations of 5/8 con-
served methionine and histidine residues abolish or reduce the function of MOR244-3; Muta-
tions of H56K and M59A from LHNPMY, M81A from PKML and M118A from
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MAYDRYVAIC reduce activity, while H243 mutants from CSAH completely abolish activity
and trafficking. Methionine and histidine have been postulated in the binding transition metals
such as copper [25] and could thus contribute to the stability of the OR protein or to the ability
of the OR to bind odorants.
The unique amino acid composition of ORs likely contributes to their functionality, and
modifying this functionality for protein expression in vitro can yield protein that may no lon-
ger reflect in vivo structure or function.
Physiological functions of odorant receptors
The unique amino acid usage of ORs we reveal in this study might have several implications
for their functionality. The organization of the olfactory system is set up such that an organism
cannot detect any odorant information if glomerular formation has not occurred. Thus, it is
more critical to olfactory function that ORs traffic to the plasma membrane where they can
contribute to axonal identity and glomerular formation rather than bind an odor with high-
affinity. In this scenario an OR with high-affinity for a given odor may not necessarily be able
to impart axon identity and so its OSNs never contribute to the coding of that olfactory stimu-
lus. By contrast, if glomerular formation occurs for axons that express an OR with weak bind-
ing affinity to an odor(s), then that OR can still contribute to stimulus detection. Thus, amino
acid usage may have more to do with the role of a specific OR in axon guidance than in ligand
detection.
It is also possible that plasma membrane targeting of ORs is linked to its role in stabilizing
the expression of a chosen OR allele during the mechanism of singular gene choice. In OSNs,
this process is critical for OR expression as robust co-expression of a 2nd OR has not been
observed. In heterologous cells, the absence of a mechanism of OR gene choice may be why
ORs also poorly traffic to the plasma membrane. If so, robust plasma membrane trafficking in
heterologous cells can only occur if those cells are tricked into “choosing” and/or “stabilizing”
an OR for expression.
Conclusion
We were surprised that our extensive mutational analysis of OR M71 failed to even partially
improve its membrane trafficking in our assay. We then realized that the nature of the OR
sequence might be fundamentally different from other 7TMs based on our in silico analysis of
the OR superfamily. Going forward, it may be difficult to readily determine a rule generalizable
to all ORs as to why many ORs fail to reach the plasma membrane, but allow some ORs to par-
tially traffic, such as OR1A1. Using both our assay and random mutagenesis of an OR that par-
tially traffics to the plasma membrane, we may be able to identify a set of mutations that help
decipher this seemingly intractable code.
Supporting Information
S1 Fig. Conserved OR sequences revealed by logo plot shared with M71, OR1A1 and
mβ2AR. (A) OR logo using mouse Class I and II odorant receptor sequences. Most highly con-
served OR residues are depicted with black circles. M71, OR1A1 and mβ2AR sequences are
delineated underneath logo plot; Residues with greater than 50% bit conservation to OR logo
are underlined. M71 residue swaps between M71 and mβ2AR are delineated in purple and
green, respectively. M71 residues converted to alanine are described with bold blue A. Con-
served residues between M71, OR1A1 and mβ2AR only are in bold and maroon. Conserved
residues between M71, OR1A1 and not mβ2AR are in bold and orange. Conserved residues
between OR1A1, mβ2AR and not M71 are in bold and light blue. Conserved residues between
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M71, mβ2AR and not OR1A1 are in bold and red. Five conserved methionine residues, three
conserved histidine residues and one weakly conserved tryptophan residue marked with aster-
isk. Two of these residues are also found in OSN expressed TAARs marked with red asterisk.
(B, C) Two examples of OR1A1::GFP transfected OP6 cells. GFP-labeled filopodia were readily
observed (arrowhead).
(EPS)
S2 Fig. Distribution of histidine, methionine and tryptophan residues in Adrenergic recep-
tors. The frequency of occurrence is displayed from NxS/T to NPxxY conserved motifs, how-
ever the graphs are all anchored by the Ct NPxxY motif.
(EPS)
S3 Fig. Distribution of histidine, methionine and tryptophan residues in Amine receptors.
The frequency of occurrence is displayed from NxS/T to NPxxY conserved motifs, however the
graphs are all anchored by the Ct NPxxY motif.
(EPS)
S4 Fig. Distribution of histidine, methionine and tryptophan residues in OR (I and II)
receptors. The frequency of occurrence is displayed from NxS/T to NPxxY conserved motifs,
however the graphs are all anchored by the Ct NPxxY motif. Three histidine and five methio-
nine residues are found at discrete regions in ORs compared all other receptor types (blue and
black asterisks); See Fig 3 for exact position. Tryptophan residues are nearly abolished in ORs
with only one conserved position (red asterisk), but distributions are conserved between
TAARs and Adrenergic receptors.
(EPS)
S5 Fig. Distribution of histidine, methionine and tryptophan residues in TAAR receptors.
The frequency of occurrence is displayed from NxS/T to NPxxY conserved motifs, however the
graphs are all anchored by the Ct NPxxY motif.
(EPS)
S1 File. Accepted and Rejected GPCR sequences.
(ZIP)
S1 Table. Raw data, amino acid content per each GPCR group.
(XLSX)
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